Edaravone
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1979 publications
Effect of edaravone on synaptic damage in Alzheimer's disease via Rho/ROCK signaling.
Journal: Pakistan journal of pharmaceutical sciences
Published: April 04, 2026
Strophioglanes A-E and (±)-Trigoxyphin K, ent-Cleistanthane Diterpenoids from Strophioblachia glandulosa var. cordifolia.
Journal: Journal of natural products
Published: March 27, 2026
Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-reperfusion rats based on KAT3B/ACSL4 pathway
Journal: Zhen ci yan jiu = Acupuncture research
Published: March 16, 2026
Correction to "Generalizability of Edaravone Efficacy".
Journal: Muscle & nerve
Published: March 14, 2026
(±)- Hyppatutions a and B, two pairs of new PPAPs with neuroprotective effect from Hypericum patulum Thunb.
Journal: Natural product research
Published: February 26, 2026
Inflamed vessel-anchored release of H2 across the blood-brain barrier for ischemic stroke neuroprotection.
Journal: Science advances
Published: February 25, 2026
The Effect of Edaravone Dexborneol Treatment After Intracranial Vascular Intervention on Inflammatory Factors and Oxidative Stress Level in Elderly Patients with Acute Ischemic Cerebrovascular Disease.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: February 17, 2026
Evolutionary adaptations of Pseudomonas aeruginosa biofilms to ciprofloxacin and antioxidant co-treatment in synthetic sputum medium.
Journal: Microbiology spectrum
Published: February 12, 2026
Evaluating the efficacy and safety of Edaravone-Dexborneol in acute ischemic stroke: an updated systematic review and meta-analysis of 7,846 Chinese patients.
Journal: The International journal of neuroscience
Published: February 08, 2026
Erratum to "Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action" [Pharmacological Reviews 78 (2025) 100101].
Journal: Pharmacological reviews
Published: February 07, 2026
The temporal mismatch between MRI-based prognostic classification and the therapeutic window.
Journal: Journal of the neurological sciences
Published: February 06, 2026
Ginkgolide B alleviates cerebral ischemia-reperfusion injury by antagonizing TRIM45 to reduce microglia-mediated neuronal damage.
Journal: Brain research bulletin
Published: January 23, 2026
Last Updated: 04/28/2026